China Metabolic Syndrome Market Report & Forecast 2021-2027

China Metabolic Syndrome Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Metabolic Syndrome Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Metabolic Syndrome Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Metabolic Syndrome Overall Market Size
2.1 China Metabolic Syndrome Market Size: 2021 VS 2027
2.2 China Metabolic Syndrome Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Metabolic Syndrome Players in China Market
3.2 Top China Metabolic Syndrome Companies Ranked by Revenue
3.3 China Metabolic Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Metabolic Syndrome Companies in China Market, by Revenue in 2020
3.5 Companies Metabolic Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Metabolic Syndrome Players in China Market
3.6.1 List of Tier 1 Metabolic Syndrome Companies in China
3.6.2 List of Tier 2 and Tier 3 Metabolic Syndrome Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Metabolic Syndrome Market Size Markets, 2021 & 2027
4.1.2 Diabetes
4.1.3 Obesity
4.1.4 Hypercholesterolemia
4.1.5 Lysosomal storage diseases
4.2 By Type - China Metabolic Syndrome Revenue & Forecasts
4.2.1 By Type - China Metabolic Syndrome Revenue, 2016-2021
4.2.2 By Type - China Metabolic Syndrome Revenue, 2022-2027
4.2.3 By Type - China Metabolic Syndrome Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Metabolic Syndrome Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - China Metabolic Syndrome Revenue & Forecasts
5.2.1 By Application - China Metabolic Syndrome Revenue, 2016-2021
5.2.2 By Application - China Metabolic Syndrome Revenue, 2022-2027
5.2.3 By Application - China Metabolic Syndrome Revenue Market Share, 2016-2027
6 Metabolic Syndrome Companies Profiles
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Details
6.1.2 Novo Nordisk Business Overview
6.1.3 Novo Nordisk Metabolic Syndrome Introduction
6.1.4 Novo Nordisk Metabolic Syndrome Revenue in China Market (2016-2021)
6.1.5 Novo Nordisk Recent Developments
6.2 Sanofi
6.2.1 Sanofi Company Details
6.2.2 Sanofi Business Overview
6.2.3 Sanofi Metabolic Syndrome Introduction
6.2.4 Sanofi Metabolic Syndrome Revenue in China Market (2016-2021)
6.2.5 Sanofi Recent Developments
6.3 Merck
6.3.1 Merck Company Details
6.3.2 Merck Business Overview
6.3.3 Merck Metabolic Syndrome Introduction
6.3.4 Merck Metabolic Syndrome Revenue in China Market (2016-2021)
6.3.5 Merck Recent Developments
6.4 AstraZeneca
6.4.1 AstraZeneca Company Details
6.4.2 AstraZeneca Business Overview
6.4.3 AstraZeneca Metabolic Syndrome Introduction
6.4.4 AstraZeneca Metabolic Syndrome Revenue in China Market (2016-2021)
6.4.5 AstraZeneca Recent Developments
6.5 Eli Lily
6.5.1 Eli Lily Company Details
6.5.2 Eli Lily Business Overview
6.5.3 Eli Lily Metabolic Syndrome Introduction
6.5.4 Eli Lily Metabolic Syndrome Revenue in China Market (2016-2021)
6.5.5 Eli Lily Recent Developments
6.6 AbbVie
6.6.1 AbbVie Company Details
6.6.2 AbbVie Business Overview
6.6.3 AbbVie Metabolic Syndrome Introduction
6.6.4 AbbVie Metabolic Syndrome Revenue in China Market (2016-2021)
6.6.5 AbbVie Recent Developments
6.7 Actelion Pharmaceuticals
6.7.1 Actelion Pharmaceuticals Company Details
6.7.2 Actelion Pharmaceuticals Business Overview
6.7.3 Actelion Pharmaceuticals Metabolic Syndrome Introduction
6.7.4 Actelion Pharmaceuticals Metabolic Syndrome Revenue in China Market (2016-2021)
6.7.5 Actelion Pharmaceuticals Recent Developments
6.8 Adocia
6.8.1 Adocia Company Details
6.8.2 Adocia Business Overview
6.8.3 Adocia Metabolic Syndrome Introduction
6.8.4 Adocia Metabolic Syndrome Revenue in China Market (2016-2021)
6.8.5 Adocia Recent Developments
6.9 Aegerion Pharmaceuticals
6.9.1 Aegerion Pharmaceuticals Company Details
6.9.2 Aegerion Pharmaceuticals Business Overview
6.9.3 Aegerion Pharmaceuticals Metabolic Syndrome Introduction
6.9.4 Aegerion Pharmaceuticals Metabolic Syndrome Revenue in China Market (2016-2021)
6.9.5 Aegerion Pharmaceuticals Recent Developments
6.10 Akros Pharma
6.10.1 Akros Pharma Company Details
6.10.2 Akros Pharma Business Overview
6.10.3 Akros Pharma Metabolic Syndrome Introduction
6.10.4 Akros Pharma Metabolic Syndrome Revenue in China Market (2016-2021)
6.10.5 Akros Pharma Recent Developments
6.11 Alnylam Pharmaceuticals
6.11.1 Alnylam Pharmaceuticals Company Details
6.11.2 Alnylam Pharmaceuticals Business Overview
6.11.3 Alnylam Pharmaceuticals Metabolic Syndrome Introduction
6.11.4 Alnylam Pharmaceuticals Metabolic Syndrome Revenue in China Market (2016-2021)
6.11.5 Alnylam Pharmaceuticals Recent Developments
6.12 Amarin
6.12.1 Amarin Company Details
6.12.2 Amarin Business Overview
6.12.3 Amarin Metabolic Syndrome Introduction
6.12.4 Amarin Metabolic Syndrome Revenue in China Market (2016-2021)
6.12.5 Amarin Recent Developments
6.13 nAmgen
6.13.1 nAmgen Company Details
6.13.2 nAmgen Business Overview
6.13.3 nAmgen Metabolic Syndrome Introduction
6.13.4 nAmgen Metabolic Syndrome Revenue in China Market (2016-2021)
6.13.5 nAmgen Recent Developments
6.14 Amicus Therapeutics
6.14.1 Amicus Therapeutics Company Details
6.14.2 Amicus Therapeutics Business Overview
6.14.3 Amicus Therapeutics Metabolic Syndrome Introduction
6.14.4 Amicus Therapeutics Metabolic Syndrome Revenue in China Market (2016-2021)
6.14.5 Amicus Therapeutics Recent Developments
6.15 Arbutus Biopharma
6.15.1 Arbutus Biopharma Company Details
6.15.2 Arbutus Biopharma Business Overview
6.15.3 Arbutus Biopharma Metabolic Syndrome Introduction
6.15.4 Arbutus Biopharma Metabolic Syndrome Revenue in China Market (2016-2021)
6.15.5 Arbutus Biopharma Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Metabolic Syndrome Market Opportunities & Trends in China Market
Table 2. Metabolic Syndrome Market Drivers in China Market
Table 3. Metabolic Syndrome Market Restraints in China Market
Table 4. Key Players of Metabolic Syndrome in China Market
Table 5. Top Metabolic Syndrome Players in China Market, Ranking by Revenue (2019)
Table 6. China Metabolic Syndrome Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Metabolic Syndrome Revenue Share by Companies, 2016-2021
Table 8. Companies Metabolic Syndrome Product Type
Table 9. List of Tier 1 Metabolic Syndrome Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Metabolic Syndrome Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Metabolic Syndrome Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Metabolic Syndrome Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Metabolic Syndrome Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Metabolic Syndrome Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Metabolic Syndrome Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Metabolic Syndrome Revenue (US$, Mn), 2022-2027
Table 17. Novo Nordisk Company Details
Table 18. Novo Nordisk Business Overview
Table 19. Novo Nordisk Metabolic Syndrome Product
Table 20. Novo Nordisk Metabolic Syndrome Revenue in China Market (2016-2021) & (US$ Million)
Table 21. Novo Nordisk Recent Developments
Table 22. Sanofi Company Details
Table 23. Sanofi Business Overview
Table 24. Sanofi Metabolic Syndrome Product
Table 25. Sanofi Metabolic Syndrome Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Sanofi Recent Developments
Table 27. Merck Company Details
Table 28. Merck Business Overview
Table 29. Merck Metabolic Syndrome Product
Table 30. Merck Metabolic Syndrome Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Merck Recent Developments
Table 32. AstraZeneca Company Details
Table 33. AstraZeneca Business Overview
Table 34. AstraZeneca Metabolic Syndrome Product
Table 35. AstraZeneca Metabolic Syndrome Revenue in China Market (2016-2021) & (US$ Million)
Table 36. AstraZeneca Recent Developments
Table 37. Eli Lily Company Details
Table 38. Eli Lily Business Overview
Table 39. Eli Lily Metabolic Syndrome Product
Table 40. Eli Lily Metabolic Syndrome Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Eli Lily Recent Developments
Table 42. AbbVie Company Details
Table 43. AbbVie Business Overview
Table 44. AbbVie Metabolic Syndrome Product
Table 45. AbbVie Metabolic Syndrome Revenue in China Market (2016-2021) & (US$ Million)
Table 46. AbbVie Recent Developments
Table 47. Actelion Pharmaceuticals Company Details
Table 48. Actelion Pharmaceuticals Business Overview
Table 49. Actelion Pharmaceuticals Metabolic Syndrome Product
Table 50. Actelion Pharmaceuticals Metabolic Syndrome Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Actelion Pharmaceuticals Recent Developments
Table 52. Adocia Company Details
Table 53. Adocia Business Overview
Table 54. Adocia Metabolic Syndrome Product
Table 55. Adocia Metabolic Syndrome Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Adocia Recent Developments
Table 57. Aegerion Pharmaceuticals Company Details
Table 58. Aegerion Pharmaceuticals Business Overview
Table 59. Aegerion Pharmaceuticals Metabolic Syndrome Product
Table 60. Aegerion Pharmaceuticals Metabolic Syndrome Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Aegerion Pharmaceuticals Recent Developments
Table 62. Akros Pharma Company Details
Table 63. Akros Pharma Business Overview
Table 64. Akros Pharma Metabolic Syndrome Product
Table 65. Akros Pharma Metabolic Syndrome Revenue in China Market (2016-2021) & (US$ Million)
Table 66. Akros Pharma Recent Developments
Table 67. Alnylam Pharmaceuticals Company Details
Table 68. Alnylam Pharmaceuticals Business Overview
Table 69. Alnylam Pharmaceuticals Metabolic Syndrome Product
Table 70. Alnylam Pharmaceuticals Metabolic Syndrome Revenue in China Market (2016-2021) & (US$ Million)
Table 71. Alnylam Pharmaceuticals Recent Developments
Table 72. Amarin Company Details
Table 73. Amarin Business Overview
Table 74. Amarin Metabolic Syndrome Product
Table 75. Amarin Metabolic Syndrome Revenue in China Market (2016-2021) & (US$ Million)
Table 76. Amarin Recent Developments
Table 77. nAmgen Company Details
Table 78. nAmgen Business Overview
Table 79. nAmgen Metabolic Syndrome Product
Table 80. nAmgen Metabolic Syndrome Revenue in China Market (2016-2021) & (US$ Million)
Table 81. nAmgen Recent Developments
Table 82. Amicus Therapeutics Company Details
Table 83. Amicus Therapeutics Business Overview
Table 84. Amicus Therapeutics Metabolic Syndrome Product
Table 85. Amicus Therapeutics Metabolic Syndrome Revenue in China Market (2016-2021) & (US$ Million)
Table 86. Amicus Therapeutics Recent Developments
Table 87. Arbutus Biopharma Business Overview
Table 88. Arbutus Biopharma Company Details
Table 89. Arbutus Biopharma Metabolic Syndrome Product
Table 90. Arbutus Biopharma Metabolic Syndrome Revenue in China Market (2016-2021) & (US$ Million)
Table 91. Arbutus Biopharma Recent Developments
List of Figures
Figure 1. Metabolic Syndrome Segment by Type
Figure 2. Metabolic Syndrome Segment by Application
Figure 3. China Metabolic Syndrome Market Overview: 2020
Figure 4. China Metabolic Syndrome Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Metabolic Syndrome Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Metabolic Syndrome Revenue in 2020
Figure 7. By Type - China Metabolic Syndrome Revenue Market Share, 2016-2027
Figure 8. By Application - China Metabolic Syndrome Revenue Market Share, 2016-2027
Figure 9. Novo Nordisk Metabolic Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Sanofi Metabolic Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Merck Metabolic Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. AstraZeneca Metabolic Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Eli Lily Metabolic Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. AbbVie Metabolic Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Actelion Pharmaceuticals Metabolic Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Adocia Metabolic Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Aegerion Pharmaceuticals Metabolic Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Akros Pharma Metabolic Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Alnylam Pharmaceuticals Metabolic Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Amarin Metabolic Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. nAmgen Metabolic Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Amicus Therapeutics Metabolic Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Arbutus Biopharma Metabolic Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs